M
About
Medincell is a pharmaceutical company specializing in the development and licensing of long-acting injectable medicines based on its proprietary MedinCell® technology. This technology allows for the controlled release of active pharmaceutical ingredients over extended periods, improving patient compliance and treatment efficacy for chronic diseases.
Technology stack
detected 2026-06-17Est. monthly stack spend~$720/mo
CDN
Cloudflare
EmailSelf-hosted
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Medincell do?
Medincell is a pharmaceutical company specializing in the development and licensing of long-acting injectable medicines based on its proprietary MedinCell® technology. This technology allows for the controlled release of active pharmaceutical ingredients over extended periods, improving patient compliance and treatment efficacy for chronic diseases.
How much funding has Medincell raised?
Medincell has raised a total of $48M in funding. The most recent round on record is Placement Privé.
Where is Medincell headquartered?
Medincell is headquartered in Engilbert, France.
When was Medincell founded?
Medincell was founded in 2003.
What industry does Medincell operate in?
Medincell operates in Biotechnology, Pharmaceuticals, HealthTech.
How many employees does Medincell have?
Medincell has approximately 100 people on record.